Contacts
Lead Organizers
Co-Chair
Aaron Green
MBA 2011
Aaron Green is a second-year MBA candidate at the MIT Sloan School of Management. Prior to joining MIT Sloan, Aaron worked as a Senior Associate at Opera Solutions, a boutique management consulting firm specializing in the financial services and private equity industries. Aaron is a graduate of Cornell University where as an undergraduate he double majored in Economics and Near Eastern Studies.
Co-Chair
Heather Vital
MBA 2011
Heather Vital is a second-year MBA Biomedical Enterprise Program (BEP) student at the MIT Sloan School of Management. Prior to Sloan, Heather worked as a project management consultant for Biotech and Pharmaceutical clients with Clarkston Consulting. Her worked included planning and executing laboratory IT implementations, program management offices (PMO), and global standardization initiatives. Heather graduated summa cum laude from Babson College with a BS in Business Administration.
Marketing & Logistics
Annelise Parham
MBA 2012
Annelise Parham is a first-year MBA student at the MIT Sloan School of Management. Before Sloan, Annelise worked at Brandeis University where she created and implemented marketing strategies in the career center. Prior to Brandeis, Annelise spent two years in the marketing department at Ramp (formerly known as EveryZing), a multimedia search and video SEO start-up company. Annelise obtained a BA in Cultural Anthropology from New York University where she graduated summa cum laude and a member of Phi Beta Kappa.
Marketing & Logistics
Rachel Wonhye Chung
MBA 2012
Rachel Chung is a first-year MBA student at the MIT Sloan School of Management. Prior to Sloan, Rachel worked as a management consultant for Oliver Wyman. Her projects included new business strategy, growth strategy and M&A strategy in healthcare and automotive industry. Rachel is a graduate of Wellesley College where she received her Bachelor's degree in International Relations with minor degree in Economics.
Marketing & Logistics
Lamees Hamada
MBA 2012
Lamees Hamada is a first year MBA student at the MIT Sloan School of Management. Prior to Sloan, Lamees worked in human resources at Pacific Alternative Asset Management Co., a fund of hedge funds. Lamees graduated from UC Irvine with a BA in Sociology.
R&D Productivity Panel Team
Panel Lead
Andrea Ippolito
Andrea is a Systems Design & Management Fellow at MIT, where she is pursuing her Masters of Science in Engineering and Management. She also serves as a Research Assistant at the Lean Advancement Initiative, where her research is focused on analyzing the stakeholders within the Military Health System to better understand the system of care surrounding Post Traumatic Stress Disorder. Prior to MIT, she worked as a Research Scientist within the Corporate Technology Development group at Boston Scientific Corporation. She obtained both her B.S in Biological Engineering in 2006 and Masters of Engineering in Biomedical Engineering in 2007 from Cornell University.
Panel Organizer
Sandra Chow
Sandra is a first year MBA student at the MIT Sloan School of Management. Prior to MIT Sloan, she worked as a pharmaceuticals analyst on the CNS Disorders team at Decision Resources where she specialized in psychiatry and pain. She obtained her Masters in 2007 from Harvard University's Biological Biomedical Sciences doctorate program, where she researched spinal cord regeneration. Sandra received her B.S. in Biology with a Minor in Brain and Cognitive Sciences and a Minor in Music from MIT in 2003.
Next Generation Technology Panel Team
Panel Lead
Chris Wilfong
Chris is an MBA candidate at the MIT Sloan School of Management in the Class of 2012. Prior to Sloan, he was Director of Portfolio Operations for Two River Group, a NY based venture firm and merchant bank focused on company creation in the life sciences industry. While at Two River, Chris co-founded and held operating roles in several public and private biotechnology companies, most recently serving as VP of Operations for Nile Therapeutics, Inc. (NASDAQ: NLTX). Chris received his BS in Economics magna cum laude from the Wharton School at the University of Pennsylvania.
Panel Organizer
David Berlin
David Berlin is in his final year of the Harvard-MIT Biomedical Enterprise Program. Prior to this, David spent four years working in clinical and sales roles for Boston Scientific's Cardiac Rhythm Management division. He continues to be passionate about commercializing innovative and disruptive medical device technology. David graduated cum laude from Washington University in St. Louis with a BS in Biomedical Engineering and an MBA.
Panel Organizer
Carlos Dedesma, Ph.D.
Carlos is a second year MBA student at MIT Sloan and a member of the Entrepreneurship & Innovation Program. Prior to MIT, Carlos worked as a pharmaceutical industry analyst at Boston-based Decision Resources. More recently he completed an Entrepreneurial Fellowship with Flagship Ventures. He trained as a neuroscientist and attained a doctorate from Weill Cornell Medical College in New York City where he investigated proliferative cells in the adult hippocampus.
Emerging Markets
Panel Lead
Eliza Kamenetsky
Eliza Kamenetsky is a first year MBA candidate at the MIT Sloan School of Management. Prior to MIT, she was an Associate in the consulting group of Leerink Swann, advising life science companies on how to maximize their revenues. Before Leerink, she worked at UK Trade & Investment, helping early stage life science companies in the UK with their market entry strategy into the US. Eliza earned bachelor's and master's degrees in Biochemistry and Molecular Biology, summa cum laude, from Boston University.
Panel Organizer
Elyssa Campbell
Elyssa Campbell is currently in the Harvard-MIT Biomedical Enterprise Program, which offers an integrated curriculum through MIT Sloan, Harvard Medical School and Harvard-MIT School of Science and Technology with a focus on transforming scientific discovery into successful innovative biomedical business. Previously Elyssa worked with Simon-Kucher and Partners conducting primary research with physicians and health insurers and helping to develop global pricing and reimbursement and marketing strategies across different phases of a product's lifecycle and across a wide range of therapeutic areas. She also worked with the World Health Organization, and contributed to the recent publication of Mental Health and Development as part of the Mental Health and Poverty Project. She received her bachelor's in Neuroscience at Dartmouth College as a Rufus Choate Scholar (Dartmouth's highest academic honor).
Panel Organizer
Jay Verrill
Jay C Verrill is a proud member of the MIT Sloan class of 2012 with a keen interest in life sciences. Jay is a former consultant at Putnam Associates where he completed over 40 projects in the pharmaceutical, biotechnology, and medical device industries. Jay developed an expertise in quantitative analysis through data mining, quantitative research methods, and forecast modeling. Prior to consulting, Jay graduated, cum laude, from Tufts University with a BA in economics.
Regulatory Uncertainty
Panel Lead
David Xie, Ph.D.
MBA 2012
David Xie is currently a first year MBA student at MIT Sloan. Prior to MIT/Sloan, he had 6 years of experience in the development and commercialization of genomic sequencing technologies and their applications in the diagnostics and drug screening markets. Most recently as a founding team member at Transfigure Medicine, a seed-stage startup focused on epigenetics technologies, David worked with Arch Venture to build the company through a combination of capital raising and business development. The projects led to its acquisition by Fate Therapeutics, a Stem Cell company based in San Diego, CA in 2009.
As a research scientist at Helicos BioSciences since its inception, he led R&D projects that helped to improve the read length, accuracy and throughput of the Single Molecule DNA Sequencing technology. After Helicos went public in 2007, David joined its product development team as a senior scientist, and led many projects to produce the $1M flagship product: HeliScope DNA sequencer.
At Sloan, David continues to deepen his interests in the commercial opportunities of the genetics and genomics sector, as he believes that new tools will create many exciting opportunities for the research, discovery and clinical markets. By education, he has a PhD in Biophysics from the University of Chicago, and a BS in Chemistry from Peking University.
Panel Organizer
Melissa Rosen
MIT SDM 2011
Melissa Rosen is currently a first year graduate student in the System Design and Management program at the Sloan School of Management and Engineering Systems Division at MIT. She is also working with Helbling Precision Engineering, a Swiss-based engineering consulting group, with focus on medical device technology development.
As a technical consultant, Melissa collaborates with global pharmaceutical companies conceiving next-generation medical devices. She has perspective in all development stages from conceptual design through regulatory approval and high volume manufacturing. Most recently, Melissa has designed and manufactured drug delivery mechanisms that are now progressing through pre-clinical trials. As well, she has developed a fabrication method for a neurostimulation electrode array implantable, which is currently being patented.
With a passion for medical devices, Melissa is interested in continuing her technical interest in drug delivery systems, implantables, and patient use systems, but is also looking to expand her expertise in biomedical business strategy, FDA regulations, and intellectual property management.
Melissa has a B.S. in Mechanical Engineering from Carnegie Mellon University and 10 years of experience in product and process design.
Hosts and Volunteers
Members of the MIT Sloan BioMedical Business Club
The MIT Sloan BioMedical Business Club is a student-run organization that promotes leadership and involvement in the life science industries comprised of biotechnology, pharmaceuticals, medical devices and healthcare. We are a forum for ideas and actions linking students, scientists, and professionals from leading universities, businesses, and non-profit organizations.
